Literature DB >> 7058831

Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients.

M P Whyte, M A Bergfeld, W A Murphy, L V Avioli, S L Teitelbaum.   

Abstract

Twenty-six women with untreated postmenopausal osteoporosis underwent iliac crest biopsy following tetracycline-labeling and mineral metabolism studies. Histomorphometric assessment of their bone remodeling rates, including formation determined by the tetracycline-labeling technique, revealed considerable variation. Eight women had no evidence of active bone formation (inactive remodeling osteoporosis), whereas the others showed a spectrum of bone formation rates (active remodeling osteoporosis). Clinical and biochemical studies failed to predict the histomorphometric findings. Postmenopausal osteoporosis is a histologically heterogeneous disorder with morphologic expression in bone that cannot be predicted by single or combined routine clinical and laboratory parameters. Bone biopsy, necessary to identify the histologic lesion and assess skeletal dynamics, may prove to be important for optimal therapy of osteoporosis, as a variety of agents--with different effects on bone remodeling--are available.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7058831     DOI: 10.1016/0002-9343(82)90810-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  44 in total

1.  Serum bone Gla protein in streak gonad syndrome.

Authors:  J Zséli; P Bösze; P Lakatos; P Vargha; G Tarján; E Kollin; C Horváth; J László; I Holló
Journal:  Calcif Tissue Int       Date:  1991-06       Impact factor: 4.333

2.  Serum bone gla protein (BGP) and other markers of bone mineral metabolism in postmenopausal osteoporosis.

Authors:  F Ismail; S Epstein; R Pacifici; D Droke; S B Thomas; L V Avioli
Journal:  Calcif Tissue Int       Date:  1986-10       Impact factor: 4.333

3.  Spatial variation in osteonal bone properties relative to tissue and animal age.

Authors:  Samuel Gourion-Arsiquaud; Jayme C Burket; Lorena M Havill; Edward DiCarlo; Stephen B Doty; Richard Mendelsohn; Marjolein C H van der Meulen; Adele L Boskey
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

Review 4.  Heterogeneity of osteoporotic syndromes and the response to calcitonin therapy.

Authors:  L V Avioli
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

Review 5.  Long-term safety of bisphosphonate therapy for osteoporosis: a review of the evidence.

Authors:  Uri A Liberman
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 6.  Review: epidemiology and pathophysiology of atypical femur fractures.

Authors:  Alvin C Ng; Meng Ai Png; David T Chua; Joyce S B Koh; Tet Sen Howe
Journal:  Curr Osteoporos Rep       Date:  2014-03       Impact factor: 5.096

7.  Bone histology in young adult osteoporosis.

Authors:  E Hills; C R Dunstan; S Y Wong; R A Evans
Journal:  J Clin Pathol       Date:  1989-04       Impact factor: 3.411

8.  Bone remodeling during the development of osteoporosis in paraplegia.

Authors:  A Chantraine; B Nusgens; C M Lapiere
Journal:  Calcif Tissue Int       Date:  1986-06       Impact factor: 4.333

9.  Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors:  R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

10.  Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption.

Authors:  R Eastell; S P Robins; T Colwell; A M Assiri; B L Riggs; R G Russell
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.